Activist profile
Bradley Louis Radoff
Campaigns
10
Proxy fights
4
Settlements
6
Directors placed
13
Style
Deal-maker
Bradley Louis Radoff is one of the U.S. shareholder activists tracked by Boardroom Alpha, with 10 disclosed campaigns since 2021. Recent U.S. targets include Genesco Inc, Atea Pharmaceuticals Inc, and Tetra Technologies Inc.
Recent activity
Notable Campaigns
| Year | Ticker | Target | Type |
|---|---|---|---|
| 2026 | GCO | Genesco Inc | Proxy fight |
| 2025 | AVIR | Atea Pharmaceuticals Inc | Cooperation agreement |
| 2025 | TTI | Tetra Technologies Inc | Proxy fight |
| 2024 | LFVN | Lifevantage Corp | Cooperation agreement |
| 2024 | EMKR | Emcore Corp | Cooperation agreement |
| 2022 | NPKI | Npk International Inc | Cooperation agreement |
| 2022 | ENZB | Enzo Biochem Inc | Cooperation agreement |
| 2021 | HHS | Harte Hanks Inc | Cooperation agreement |
| 2021 | TTI | Tetra Technologies Inc | Cooperation agreement |
Full campaign history, dissident slates, per-nominee seat outcomes, and filings timelines inside the platform →
Inside Boardroom Alpha
The full Bradley Louis Radoff profile
- →Daily-rescored target prediction from the activist's current 13F overlap
- →Full detail on every activist board nominee and the election or settlement result
- →Per-campaign effectiveness scoring across vote outcomes and concessions
- →Composite influence, vote-strength, and negotiating-leverage scoring
- →Preferred legal counsel, proxy solicitor, and IR/PR provider history